Anti-aging skin care formulations

Cosmetic Formulation of Skin Care Products

Volumn , Issue , 2005, Pages 167-186

  Bissett, Donald L ^a  

^a Miami Valley Innovation Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123745244     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (69)

1. Davies PJA, Basilion JP, Haake AR. Intrinsic biology of retinoids in the skin. In: Goldsmith LA, ed. In: Physiology, Biochemistry, and Molecular Biology of the Skin, Vol. 1. New York: Oxford University Press, 1997:385-409.
2. Varani J, Fisher GJ, Kang S, et al. Molecular mechanisms of intrinsic skin aging and retinoid-induced repair and reversal. J Invest Dermatol Symp Proc 1998; 3:57-60.
3. Kang S, Duell EA, Fisher GJ, et al. Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels of irritation. J Invest Dermatol 1995; 105:549-556.
4. Gonzalez S, Moran M, Kochevar IE. Chronic photodamage in skin of mast cell-deficient mice. Photochem Photobiol 1999; 70:248-253.
5. Dunstan RW, Kennis RA. Selected heritable skin diseases of domesticated animals. In: Sundberg JP, ed. Handbook of Mouse Mutations with Skin and Hair Abnormalities. Boca Raton, Florida: CRC Press, 1994:524-525.
6. Kligman AM, Baker TJ, Gordon HL. Long-term histologic follow-up of phenol face peels. Plast Reconstr Surg 1975; 75:652-659.
7. Schwartz E, Kligman LH. Topical tretinoin increases the tropoelastin and fibronectin content of photoaged hairless mouse skin. J Invest Dermatol 1995; 104:518-522.
8. Griffiths CE, Finkel LJ, Tranfaglia MG, et al. An in vivo experimental model for effects of topical retinoic acid in human skin. Br J Dermatol 1993; 129:389-394.
9. Erling T. Skin treatment with two different galenical formulations of retinyl palmitate in humans. J Appl Cosmetol 1993; 11:71-76.
10. Creidi P, Humbert P. Clinical use of topical retinaldehyde on photoaged skin. Dermatol 1999; 199S:49-52.
11. Diridollou S, Vienne MP, Alibert M, et al. Efficacy of topical 0.05% retinaldehyde in skin aging by ultrasound and rheological techniques. Dermatol 1999; 199S:37-41.
12. Creidi P, Vienne MP, Ochonishy S, et al. Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol 1998; 39:960-965.
13. Fluhr JW, Vienne MP, Lauze C, et al. Tolerance profile of retinol, retinaldehyde, and retinoic acid under maximized and long-term clinical conditions. Dermatol 1999; 199S:57-60.
14. Matts PJ, Oblong JE, Bissett DL. A review of the range of effects of niacinamide in human skin. Int Fed Soc Cosmet Chem Magn 2002; 5:285-289.
15. Bissett DL. Topical niacinamide and barrier enhancement. Cutis 2002; 70S:8-12.
16. Bissett DL, Oblong JE, Saud A, et al. Topical niacinamide provides skin aging appearance benefits while enhancing barrier function. J Clin Dermatol 2003; 32S:9-18.
17. Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002; 147:22-33.
18. Bissett DL, Miyamoto K, Sun P, et al. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci 2004; 26:231-238.
19. Tanno O, Ota Y, Kitamura N, et al. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Brit J Dermatol 2000; 143:525-531.
20. Griffiths CEM. Nicotinamide 4% gel for the treatment of inflammatory acne vulgaris. J Dermatol Treat 1995; 6S:8-10.
21. Ungerstedt JS, Blomback M, Soderstrom T. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol 2003; 131:48-52.
22. Gebicki J, Sysa-Jedrzejowska A, Adamus J, et al. 1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin. Pol J Pharmacol 2003; 55:109-112.
23. Wu JT. Advanced glycosylation end products: a new disease marker for diabetes and aging. J Clin Lab Anal 1993; 7:252-255.
24. Vlassara H. Recent progress on the biologic and clinical significance of advanced glycosylation end products. J Lab Clin Med 1994; 124:19-30.
25. WolffSP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic Biol Med 1991; 10:339-352.
26. Dyer DG, Dunn JA, Thorpe SR, et al. Accumulation of maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993; 91:2463-2469.
27. Odetti P, Pronzato MA, Noberasco G, et al. Relationships between glycation and oxidation related fluorescence in rat collagen during aging. Lab Invest 1994; 70:61-67.
28. Reber F, Geffarth R, Kasper M, et al. Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection. Graefes Arch Clin Exp Ophthalmol 2003; 241:213-225.
29. Thornalley PJ. Glycation in diabetic reuropathy: characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol 2002; 50:37-57.
30. Andersson RG, Aberg G, Brattsand R, et al. Studies on the mechanism of flush induced by nicotinic acid. Acta Pharmacol Toxicol 1977; 41:1-10.
31. Jacobson MK, Kim H, Kim M, et al. Modulating NAD-dependent DNA repair and transcription regulated pathways of skin homeostatis: evaluation in human subjects. New Orleans, LA: Poster, 60th Annual Meeting of the American Academy of Dermatology, Feb 2002:22-27.
32. Alster TS, West TB. Effect of topical vitamin C on postoperative carbon dioxide laser resurfacing erythema. Dermatol Surg 1998; 24:331-334.
33. Tajima S, Pinnell SR. Ascorbic acid preferentially enhances type I and III collagen gene transcription in human skin fibroblasts. J Dermatol Sci 1996; 11:250-253.
34. Phillips CL, Combs SB, Pinnell SR. Effects of ascorbic acid on proliferation and collagen synthesis in relation to the donor age of human dermal fibroblasts. J Invest Dermatol 1994; 103:228-232.
35. Geesin JC, Darr D, Kaufman R, et al. Ascorbic acid specifically increases type I and type III pro-collagen messenger RNA levels in human skin fibroblasts. J Invest Dermatol 1988; 90:420-124.
36. Pinnell SR. Regulation of collagen biosynthesis by ascorbic acid: a review. Yale J Biol Med 1985; 58:553-559.
37. Raschke T, Koop U, Dusing HJ, et al. Topical activity of ascorbic acid: from in vitro optimization to in vivo efficacy. Skin Pharmacol Physiol 2004; 17:200-206.
38. Fitzpatrick RE, Rostan EF. Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg 2002; 28:231-236.
39. Humbert PG, Haftek M, Creidi P, et al. Topical ascorbic acid on photoaged skin: clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo. Exp Dermatol 2003; 12:237-244.
40. Traikovich SS. Use of topical ascorbic acid and its effects on photodamaged skin topography. Arch Otolaryngol Head Neck Surg 1999; 125:1091-1098.
41. Katayama K, Armendariz-Borunda J, Raghow R, et al. A pentapeptide from type procollagen promotes extracellular matrix production. J Biol Chem 1993; 268:9941-9944.
42. Foldvari M, Attah-Poku S, Hu J, et al. Palmitoyl derivatives of interferon alpha: potent for cutaneous delivery. J Pharm Sci 1998; 87:1203-1208.
43. Robinson L, Fitzgerald N, Berge C, et al. Pentapeptide offers improvement in human photoaged facial skin. Ann Dermatol Venereol 2002; 129:1S405.
44. Lintner K, Mas-Chamberlin C, Mondon P. Pentapeptide facilitates matrix regeneration of photoaged skin. Ann Dermatol Venereol 2002; 129:1S401.
45. Lintner K. Promoting ECM production without compromising barrier. Ann Dermatol Venereol 2002; 129:1S105.
46. Pickart L. Copperceuticals and the skin. Cosmet Toilet 2003; 118:24-28.
47. Smith-Mungo LL, Kagan HM. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol 1998; 16:387-398.
48. Canapp SO, Farese JP, Schultz GS, et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg 2003; 32:515-523.
49. Simeon A, Wegrowski Y, Bontemps Y, et al. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. J Invest Dermatol 2000; 115:962-968.
50. Simeon A, Emonard H, Hornebeck W, et al. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2 C stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci 2000; 67:2257-2265.
51. Simeon A, Monier F, Emonard H, et al. Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2 +. J Invest Dermatol 1999; 112:957-964.
52. Buffoni F, Pino R, Dal Pozzo A. Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts. Arch Int Pharmacodyn Ther 1995; 330:345-360.
53. Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Queensland, Australia: Presentation, 37th Annual Conference of the Australian Society of Cosmetic Chemists, 2003 March:13-16.
54. Mas-Chamberlin C, Lintner K, Basset L, et al. Relevance of antiwrinkle treatment of a peptide: 4 months clinical double blind study vs excipient. Ann Dermatol Venereol 2002; 129:1S456.
55. Kruger N, Fiegert L, Becker D, et al. For the treatment of skin aging: trace elements in form of a complex of copper tripeptide. Cosmet Med 2003; 24:31-33.
56. Appa Y, Stephens T, Barkovic S, et al. A clinical evaluation of a copper-peptide-containing liquid foundation and cream concealer designed for improving skin condition. New Orleans, LA: Poster #66, 60th Annual Meeting of the American Academy of Dermatology 2002:22-27.
57. Leyden JJ, GroveG, Barkovic S, et al. The Effect of Tripeptide to Copper Ratio in Two Copper Peptide Creams On Photoaged Facial Skin. New Orleans, LA: Poster #67, 60th Annual Meeting of the American Academy of Dermatology, 2002 Feb.:22-27.
58. th Annual Meeting of the American Academy of Dermatology, 2002 Feb:22-27.
59. Leyden JJ, Stephens T, Finkey MB, et al. Skin Care Benefits Of Copper Peptide Containing Eye Creams. New Orleans, LA: Poster #69, 60th Annual Meeting of the American Academy of Dermatology 2002 Feb.:22-27.
60. Cole CA, Bertin C. Dimethylaminoethanol: a new skin-care ingredient for aging skin. In: Baran R, Maibach HI, eds. Textbook of Cosmetic Dermatology. 3rd ed. Abingdon, Oxon, U.K.: Taylor & Francis, 2005:95-101.
61. Nagy I, Floyd RA. Electron spin resonance spectroscopic demonstration of the hydroxyl free radical scavenger properties of dimethylaminoethanol in spin trapping experiments confirming the molecular basis for the biological effects of centrophenoxine. Arch Gerontol Geriatr 1984; 3:297-310.
62. Nagy I, Nagy K. On the role of corss-linking of cellular proteins in aging. Mech Ageing Dev 1980; 14:245-251.
63. Uhoda I, Faska N, Robert C, et al. Split-face study on the cutaneous tensile effect of 2-dimethylaminoethanol (deanol) gel. Skin Res Technol 2002; 8:164-167.
64. Levy SB. In: Baran R, Maibach HI, eds. Textbook of Cosmetic Dermatology. 3rd ed. Abingdon, Oxon, U.K.: Taylor & Francis, 2005:129-132.
65. Lu L, Ying K, Wei SM, et al. Asiaticoside induction for cell-cycle progression, proliferation and collagen synthesis in human dermal fibroblasts. Int J Dermatol 2004; 43:801-807.
66. Yarosh DB, Both D, Brown D. Liposomal ursolic acid (Merotaine) increases ceramides and collagen in human skin. Horm Res 2000; 54:318-321.
67. Martelli L, Berardesca E, Martelli M. Topical formulation of a new plant extract complex with refirming properties: clinical and non-invasive evaluation in a double-blind trial. Int J Cosmet Sci 2000; 22:201-206.
68. Passi S, De Pita O, Grandinetti M, et al. The combined use of oral and topical lipophilic antioxidants increases their levels both in sebum and stratum corneum. Biofactors 2003; 18:289-297.
69. Stab F, Wolber R, Blatt T, et al. Topically applied antioxidants in skin protection. Methods Enzymol 2000; 319:465-478.